Published in Invest Ophthalmol Vis Sci on December 01, 2010
Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res (2001) 2.19
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci (2007) 2.05
Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. Invest Ophthalmol Vis Sci (2010) 1.18
Recombinant human VEGF165b inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2010) 1.17
Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors. J Transl Med (2010) 1.15
Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E. J Virol (2008) 1.07
Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. J Gene Med (2010) 1.01
Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model. Curr Eye Res (2010) 0.92
Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model. Acta Ophthalmol (2010) 0.89
Nucleotide sequence and expression of the porcine vascular endothelial growth factor. Biochim Biophys Acta (1995) 0.82
Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis). Am J Ophthalmol (2009) 3.47
Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci (2009) 1.90
Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol (2012) 1.47
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity. Vaccine (2009) 1.09
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. Elife (2013) 1.06
Assistant-independent OptiFlex system for contact and noncontact wide-angle viewing in vitreoretinal surgery. Arch Ophthalmol (2010) 1.05
A review: role of ultraviolet radiation in age-related macular degeneration. Eye Contact Lens (2011) 1.03
Comparative in vitro safety analysis of dyes for chromovitrectomy: indocyanine green, brilliant blue green, bromophenol blue, and infracyanine green. Retina (2011) 1.00
SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γ. PLoS One (2012) 0.99
Differential effects of TGFbeta and vitreous on the transformation of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2009) 0.99
Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium. J Endocrinol (2007) 0.98
In-vivo high resolution imaging of optic nerve head drusen using spectral-domain Optical Coherence Tomography. BMC Med Imaging (2010) 0.98
Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent manner. PLoS One (2012) 0.95
Evaluation of cytotoxic effects of bevacizumab on human corneal cells. Cornea (2009) 0.95
Infrared imaging and spectral-domain optical coherence tomography findings correlate with microperimetry in acute macular neuroretinopathy: a case report. J Med Case Rep (2011) 0.95
Evaluation of differential toxicity of varying doses of bevacizumab on retinal ganglion cells, retinal pigment epithelial cells, and vascular endothelial growth factor-enriched choroidal endothelial cells. J Ocul Pharmacol Ther (2009) 0.94
Tumor necrosis factor-alpha (TNF-α) levels in aqueous humor of primary open angle glaucoma. Clin Ophthalmol (2011) 0.90
The role of lutein in eye-related disease. Nutrients (2013) 0.89
Fundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathy. Eur J Ophthalmol (2011) 0.89
Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables. Retina (2009) 0.88
Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells. Mol Vis (2013) 0.88
Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells. Mol Vis (2010) 0.88
Retinal Thickness Normative Data in Wild-Type Mice Using Customized Miniature SD-OCT. PLoS One (2013) 0.87
In vitro evaluation of bevacizumab toxicity on a retinal ganglion cell line. Acta Ophthalmol (2009) 0.86
Hypoxia initiates sirtuin1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor-2α. Mol Vis (2012) 0.85
Evaluation of ultraviolet light toxicity on cultured retinal pigment epithelial and retinal ganglion cells. Clin Ophthalmol (2010) 0.84
Modified protocol for in vivo imaging of wild-type mouse retina with customized miniature spectral domain optical coherence tomography (SD-OCT) device. Biol Proced Online (2012) 0.84
Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible? PLoS One (2012) 0.84
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells. Mol Vis (2011) 0.83
Lutein protects retinal pigment epithelium from cytotoxic oxidative stress. Cutan Ocul Toxicol (2013) 0.82
Evaluation of sirtuin role in neuroprotection of retinal ganglion cells in hypoxia. Invest Ophthalmol Vis Sci (2012) 0.81
Self-stabilizing wide-angle contact lens for vitreous surgery. Retina (2003) 0.81
Temporal macular thinning on spectral-domain optical coherence tomography in proliferative sickle cell retinopathy. Arch Ophthalmol (2011) 0.81
Evaluation of proton beam radiation sensitivity of proliferating choroidal endothelial and retinal ganglion cells with clonogenic assay. Cutan Ocul Toxicol (2011) 0.81
Accurate estimation of vascular endothelial growth factor levels in microsamples with a low-cost bead-based assay. Retina (2010) 0.80
Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle. Clin Ophthalmol (2013) 0.80
Newly designed self-retaining prism contact lens for vitreous surgery. Retina (2003) 0.80
Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples. Clin Ophthalmol (2011) 0.80
ProtEx technology for the generation of novel therapeutic cancer vaccines. Exp Mol Pathol (2009) 0.79
Immunocytochemical localization of polyamines during attachment and spreading of retinal pigment epithelial and intestinal epithelial cells. Cell Motil Cytoskeleton (2004) 0.77
Autoclavable wide-angle contact lens for vitreous surgery. Am J Ophthalmol (2004) 0.76
Acute, bilateral, concurrent central retinal artery occlusion in sickle cell disease after use of tadalafil (Cialis). JAMA Ophthalmol (2013) 0.76
Deprivation of bFGF Promotes Spontaneous Differentiation of Human Embryonic Stem Cells into Retinal Pigment Epithelial Cells. J Stem Cells (2015) 0.76
Aplastic anemia induced disc edema and visual loss in pregnancy: a case report. Cases J (2008) 0.76
Mechanism of rLcrV and rYopB mediated Immunosuppression in murine peritoneal macrophages. Mol Immunol (2004) 0.76
Vitreous induces heme oxygenase-1 expression mediated by transforming growth factor-beta and reactive oxygen species generation in human retinal pigment epithelial cells. Mol Vis (2007) 0.76
Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol (2005) 0.75
Spectral Domain OCT Documented Resolution of Pseudophakic Cystoid Macular Edema after Intravitreal Triamcinolone. Ophthalmol Eye Dis (2010) 0.75
Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines. Oncoimmunology (2013) 0.75
Limitations in assessing nerve growth factor levels in aqueous humor samples from human eyes. BMC Res Notes (2008) 0.75
Differential sensitivity of choroidal endothelial, retinal ganglion, and retinal pigment epithelial cells in vitro to proton radiation. Am J Ophthalmol (2013) 0.75
TEMPORAL THINNING IN SICKLE CELL RETINOPATHY IS ASSOCIATED WITH DIMINISHED PERFUSION ON OCTA AND DENSE SCOTOMA ON MICROPERIMETERY. Retin Cases Brief Rep (2017) 0.75
EXTREME DIURNAL VARIATION OF CENTRAL MACULAR THICKNESS IN DIABETIC MACULAR EDEMA. Retin Cases Brief Rep (2017) 0.75
Webcasts for resident education. Ophthalmology (2012) 0.75
Evaluation of choroidal endothelial cell proliferation after exposure to varying doses of proton beam radiation. Retina (2011) 0.75
The direct display of costimulatory proteins on tumor cells as a means of vaccination for cancer immunotherapy. Methods Mol Biol (2014) 0.75
Intraocular segment of the central retinal vein. Ophthalmic Surg Lasers Imaging (2005) 0.75